{"prompt": "['Charit\u00e9 Universit\u00e4tsmedizin Berlin', 'Prof. Dr. med. Dominik Modest', 'FIRE-9 PORT', '28-Sep-2021', 'EudraCT no. 2020-006144-18', 'Protocol Version 3.0', 'Schmoll HJ, Van Cutsem E, Stein A, et al. ESMO Consensus Guidelines for management of patients', 'with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol', '2012; 23(10), 2479-2516.', 'Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al. Global burden of cancer in 2008: a systematic', 'analysis of disability-adjustec life-years in 12 world regions. Lancet 2012; 380(9856): 1840-', '50.', 'Siegel R, Naishadham D & Jemal A Cancer statistics, 2012. CA Cancer J Clin 2012; 62(1), 10-29', 'Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in', 'advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22(2), 229-237.', 'Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of', 'patients with metastatic colorectal cancer. Ann Oncol 2016; 27(8): 1386-422.', 'Confidential', 'Page 72 of 79']['Charit\u00e9 Universit\u00e4tsmedizin Berlin', 'Prof. Dr. med. Dominik Modest', 'FIRE-9 PORT', '28-Sep-2021', 'EudraCT no. 2020-006144-18', 'Protocol Version 3.0', '12 Appendices', 'Appendix 1: ECOG Performance Status', 'Grade', 'Description', '0', 'Normal activity. Fully active, able to carry on all pre-disease', 'performance without restriction.', 'Symptoms, but ambulatory. Restricted in physically strenuous', '1', 'activity, but ambulatory and able to carry out work of a light or', 'sedentary nature (e.g., light housework, office work).', 'In bed < 50% of the time. Ambulatory and capable of all self-care, but', '2', 'unable to carry out any work activities. Up and about more than 50%', 'of waking hours.', '3', 'In bed > 50% of the time. Capable of only limited self-care, confined', 'to bed or chair more than 50% of waking hours.', '4', '100% bedridden. Completely disabled. Cannot carry on any self-', 'care. Totally confined to bed or chair.', '5', 'Dead.', '*', 'As published in Am. J. Clin. Oncol.: Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis,', 'T.E., McFadden, E.T., Carbone, P.P.: Toxicity And Response Criteria Of The Eastern', 'Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982. The Eastern Cooperative', 'Oncology Group, Robert Comis M.D., Group Chair.', 'Confidential', 'Page 73 of 79']['Charit\u00e9 Universit\u00e4tsmedizin Berlin', 'Prof. Dr. med. Dominik Modest', 'FIRE-9 PORT', '28-Sep-2021', 'EudraCT no. 2020-006144-18', 'Protocol Version 3.0', 'Appendix 2: Common Terminology Criteria for Adverse Events V5.0 (CTCAE)', 'The descriptions and grading scales found in the revised NCI Common Terminology', 'Criteria for Adverse Events (CTCAE) version 5.0 will be utilized for adverse event', 'reporting. (http://ctep.cancer.gov/reporting/ctc.html)', 'Confidential', 'Page 74 of 79']\n\n###\n\n", "completion": "END"}